Brucellosis Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

the publisher’s report on the global brucellosis vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global brucellosis vaccine market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global brucellosis vaccine market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global brucellosis vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global brucellosis vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global brucellosis vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global brucellosis vaccine market.

The report delves into the competitive landscape of the global brucellosis vaccine market. Key players operating in the global brucellosis vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global brucellosis vaccine market profiled in this report.

Key Questions Answered in Brucellosis Vaccine Market Report

What is the sales/revenue generated by brucellosis vaccines across all regions during the forecast period?
What are the opportunities in the global brucellosis vaccine market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which type is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the global market?

Brucellosis Vaccine Market - Research Objectives and Research Approach

The comprehensive report on the global brucellosis vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives of this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global brucellosis vaccine market in terms of type, vaccine type, application, distribution channel, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global brucellosis vaccine market.

Frequently Asked Questions about the Global Brucellosis Vaccine Market

What is the estimated value of the Global Brucellosis Vaccine Market?

The Global Brucellosis Vaccine Market was estimated to be valued at $262.5 Million in 2021.

What is the growth rate of the Global Brucellosis Vaccine Market?

The growth rate of the Global Brucellosis Vaccine Market is 4.0%, with an estimated value of $387.5 Million by 2031.

What is the forecasted size of the Global Brucellosis Vaccine Market?

The Global Brucellosis Vaccine Market is estimated to be worth $387.5 Million by 2031.

Who are the key companies in the Global Brucellosis Vaccine Market?

Key companies in the Global Brucellosis Vaccine Market include Merck Animal Health, Ceva Sante Animale, CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation., Fivet Animal Health and industries Center.

Report Attribute	Details
No. of Pages	180
Published	November 2021
Forecast Period	2021 - 2031
Estimated Market Value ( USD ) in 2021	$ 262.5 Million
Forecasted Market Value ( USD ) by 2031	$ 387.5 Million
Compound Annual Growth Rate	4.0%
Regions Covered	Global

1. Preface

1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Brucellosis Vaccine Market Forecast
4.4. Global Brucellosis Vaccine Market Outlook

5. Market Outlook

5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. Disease Prevalence globally with key countries
5.3. Regulatory Scenario
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Brucellosis Vaccine Market Analysis and Forecast, by Type

6.1. Introduction
6.2. Global Brucellosis Vaccine Market Value Share Analysis, by Type
6.3. Global Brucellosis Vaccine Market Forecast, by Type
6.3.1. RB51 Vaccine
6.3.2. S19 Vaccine
6.3.3. Others
6.4. Global Brucellosis Vaccine Market Analysis, by Type
6.5. Global Brucellosis Vaccine Market Attractiveness Analysis, by Type

7. Global Brucellosis Vaccine Market Analysis and Forecast, by Vaccine Type

7.1. Introduction
7.2. Global Brucellosis Vaccine Market Value Share Analysis, by Vaccine Type
7.3. Global Brucellosis Vaccine Market Forecast, by Vaccine Type
7.3.1. DNA Vaccine
7.3.2. Subunit Vaccine
7.3.3. Vector Vaccine
7.4. Recombinant Vaccine
7.5. Global Brucellosis Vaccine Market Analysis, by Vaccine Type
7.6. Global Brucellosis Vaccine Market Attractiveness Analysis, by Vaccine Type

8. Global Brucellosis Vaccine Market Analysis and Forecast, by Application

8.1. Introduction
8.2. Global Brucellosis Vaccine Market Value Share Analysis, by Application
8.3. Global Brucellosis Vaccine Market Forecast, by Application
8.3.1. Cattle
8.3.2. Sheep & Goat
8.3.3. Others
8.4. Global Brucellosis Vaccine Market Analysis, by Application
8.5. Global Brucellosis Vaccine Market Attractiveness Analysis, by Application

9. Global Brucellosis Vaccine Market Analysis and Forecast, by Distribution Channel

9.1. Introduction
9.2. Global Brucellosis Vaccine Market Value Share Analysis, by Distribution Channel
9.3. Global Brucellosis Vaccine Market Forecast, by Distribution Channel
9.3.1. Veterinary Hospitals & Clinics
9.3.2. Retail Channels
9.3.3. Others
9.4. Global Brucellosis Vaccine Market Analysis, by Distribution Channel
9.5. Global Brucellosis Vaccine Market Attractiveness Analysis, by Distribution Channel

10. Global Brucellosis Vaccine Market Analysis, by Region

10.1. Global Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Region
10.2. Global Brucellosis Vaccine Market Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa

11. North America Brucellosis Vaccine Market Analysis

11.1. North America Brucellosis Vaccine Market Overview
11.2. North America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Country
11.3. North America Brucellosis Vaccine Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Type
11.5. North America Brucellosis Vaccine Market Forecast, by Type
11.5.1. RB51 Vaccine
11.5.2. S19 Vaccine
11.5.3. Others
11.6. North America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Vaccine Type
11.7. North America Brucellosis Vaccine Market Forecast, by Vaccine Type
11.7.1. DNA Vaccine
11.7.2. Subunit Vaccine
11.7.3. Vector Vaccine
11.7.4. Recombinant Vaccine
11.8. North America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Application
11.9. North America Brucellosis Vaccine Market Forecast, by Application
11.9.1. Cattle
11.9.2. Sheep & Goat
11.9.3. Others
11.10. North America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Distribution Channel
11.11. North America Brucellosis Vaccine Market Forecast, by Distribution Channel
11.11.1. Veterinary Hospitals & Clinics
11.11.2. Retail Channels
11.11.3. Others

12. Europe Brucellosis Vaccine Market Analysis

12.1. Europe Brucellosis Vaccine Market Overview
12.2. Europe Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Europe Brucellosis Vaccine Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Spain
12.3.5. Italy
12.3.6. Rest of Europe
12.4. Europe Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Type
12.5. Europe Brucellosis Vaccine Market Forecast, by Type
12.5.1. RB51 Vaccine
12.5.2. S19 Vaccine
12.5.3. Others
12.6. Europe Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Vaccine Type
12.7. Europe Brucellosis Vaccine Market Forecast, by Vaccine Type
12.7.1. DNA Vaccine
12.7.2. Subunit Vaccine
12.7.3. Vector Vaccine
12.7.4. Recombinant Vaccine
12.8. Europe Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Application
12.9. Europe Brucellosis Vaccine Market Forecast, by Application
12.9.1. Cattle
12.9.2. Sheep & Goat
12.9.3. Others
12.10. Europe Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Distribution Channel
12.11. Europe Brucellosis Vaccine Market Forecast, by Distribution Channel
12.11.1. Veterinary Hospitals & Clinics
12.11.2. Retail Channels
12.11.3. Others

13. Asia Pacific Brucellosis Vaccine Market Analysis

13.1. Asia Pacific Brucellosis Vaccine Market Overview
13.2. Asia Pacific Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Asia Pacific Brucellosis Vaccine Market Forecast, by Country/Sub-region
13.3.1. China
13.3.2. Japan
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Type
13.5. Asia Pacific Brucellosis Vaccine Market Forecast, by Type
13.5.1. RB51 Vaccine
13.5.2. S19 Vaccine
13.5.3. Others
13.6. Asia Pacific Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Vaccine Type
13.7. Asia Pacific Brucellosis Vaccine Market Forecast, by Vaccine Type
13.7.1. DNA Vaccine
13.7.2. Subunit Vaccine
13.7.3. Vector Vaccine
13.7.4. Recombinant Vaccine
13.8. Asia Pacific Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Application
13.9. Asia Pacific Brucellosis Vaccine Market Forecast, by Application
13.9.1. Cattle
13.9.2. Sheep & Goat
13.9.3. Others
13.10. Asia Pacific Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Distribution Channel
13.11. Asia Pacific Brucellosis Vaccine Market Forecast, by Distribution Channel
13.11.1. Veterinary Hospitals & Clinics
13.11.2. Retail Channels
13.11.3. Others

14. Latin America Brucellosis Vaccine Market Analysis

14.1. Latin America Brucellosis Vaccine Market Overview
14.2. Latin America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Latin America Brucellosis Vaccine Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Type
14.5. Latin America Brucellosis Vaccine Market Forecast, by Type
14.5.1. RB51 Vaccine
14.5.2. S19 Vaccine
14.5.3. Others
14.6. Latin America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Vaccine Type
14.7. Latin America Brucellosis Vaccine Market Forecast, by Vaccine Type
14.7.1. DNA Vaccine
14.7.2. Subunit Vaccine
14.7.3. Vector Vaccine
14.7.4. Recombinant Vaccine
14.8. Latin America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Application
14.9. Latin America Brucellosis Vaccine Market Forecast, by Application
14.9.1. Cattle
14.9.2. Sheep & Goat
14.9.3. Others
14.10. Latin America Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Distribution Channel
14.11. Latin America Brucellosis Vaccine Market Forecast, by Distribution Channel
14.11.1. Veterinary Hospitals & Clinics
14.11.2. Retail Channels
14.11.3. Others

15. Middle East & Africa Brucellosis Vaccine Market Analysis

15.1. Middle East & Africa Brucellosis Vaccine Market Overview
15.2. Middle East & Africa Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Middle East & Africa Brucellosis Vaccine Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Type
15.5. Middle East & Africa Brucellosis Vaccine Market Forecast, by Type
15.5.1. RB51 Vaccine
15.5.2. S19 Vaccine
15.5.3. Others
15.6. Middle East & Africa Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Vaccine Type
15.7. Middle East & Africa Brucellosis Vaccine Market Forecast, by Vaccine Type
15.7.1. DNA Vaccine
15.7.2. Subunit Vaccine
15.7.3. Vector Vaccine
15.7.4. Recombinant Vaccine
15.8. Middle East & Africa Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Application
15.9. Middle East & Africa Brucellosis Vaccine Market Forecast, by Application
15.9.1. Cattle
15.9.2. Sheep & Goat
15.9.3. Others
15.10. Middle East & Africa Brucellosis Vaccine Market Value Share and Attractiveness Analysis, by Distribution Channel
15.11. Middle East & Africa Brucellosis Vaccine Market Forecast, by Distribution Channel
15.11.1. Veterinary Hospitals & Clinics
15.11.2. Retail Channels
15.11.3. Others

16. Competition Landscape

16.1. Company Profiles
16.1.1. Merck Animal Health
16.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.1.2. Product Portfolio
16.1.1.3. Financial Overview
16.1.1.4. SWOT Analysis
16.1.1.5. Strategic Overview
16.1.2. Ceva Sante Animale
16.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.2.2. Product Portfolio
16.1.2.3. SWOT Analysis
16.1.2.4. Strategic Overview
16.1.3. CZ Vaccines
16.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.3.2. Product Portfolio
16.1.3.3. SWOT Analysis
16.1.3.4. Strategic Overview
16.1.4. Colorado Serum Company
16.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.4.2. Product Portfolio
16.1.4.3. SWOT Analysis
16.1.4.4. Strategic Overview
16.1.5. Indian Immunologicals Ltd.
16.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.5.2. Product Portfolio
16.1.5.3. SWOT Analysis
16.1.5.4. Strategic Overview
16.1.6. Hester Biosciences Limited
16.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.6.2. Product Portfolio
16.1.6.3. Financial Overview
16.1.6.4. SWOT Analysis
16.1.6.5. Strategic Overview
16.1.7. Veterinary Technologies Corporation.
16.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.7.2. Product Portfolio
16.1.7.3. SWOT Analysis
16.1.7.4. Strategic Overview
16.1.8. Fivet Animal Health
16.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.8.2. Product Portfolio
16.1.8.3. SWOT Analysis
16.1.8.4. Strategic Overview
16.1.9. Jordan Bio-industries Center
16.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.9.2. Product Portfolio
16.1.9.3. SWOT Analysis
16.1.9.4. Strategic Overview
16.1.10. Laboratories Tornel
16.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.10.2. Product Portfolio
16.1.10.3. SWOT Analysis
16.1.10.4. Strategic Overview

List of Tables

Table 1: U.S. Fluoroscopy Navigation Technology Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 2: U.S. Fluoroscopy Navigation Technology Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 3: U.S. & Canada Fluoroscopy Navigation Technology Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 4: Canada Fluoroscopy Navigation Technology Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 5: Canada Fluoroscopy Navigation Technology Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 6: Canada Fluoroscopy Navigation Technology Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Brucellosis Vaccine Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Brucellosis Vaccine Market Value Share, by Type, 2020
Figure 03: Global Brucellosis Vaccine Market Value Share, by Vaccine Type, 2020
Figure 04: Global Brucellosis Vaccine Market Value Share, by Region, 2020
Figure 05: Global Brucellosis Vaccine Market Value Share, by Application, 2020
Figure 06: Global Brucellosis Vaccine Market Value Share, by Distribution Channel, 2020
Figure 07: Global Brucellosis Vaccine Market Value Share Analysis, by Type, 2020 and 2031
Figure 08: Global Brucellosis Vaccine Market Revenue (US$ Mn), by RB51 Vaccine, 2017-2031
Figure 09: Global Brucellosis Vaccine Market Revenue (US$ Mn), by S19 Vaccine, 2017-2031
Figure 10: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Others, 2017-2031
Figure 11: Global Brucellosis Vaccine Market Attractiveness Analysis, by Type, 2021-2031
Figure 12: Global Brucellosis Vaccine Market Value Share Analysis, by Vaccine Type, 2020 and 2031
Figure 13: Global Brucellosis Vaccine Market Revenue (US$ Mn), by DNA Vaccine, 2017-2031
Figure 14: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Subunit Vaccine, 2017-2031
Figure 15: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Vector Vaccine, 2017-2031
Figure 16: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Recombinant Vaccine, 2017-2031
Figure 17: Global Brucellosis Vaccine Market Attractiveness Analysis, by Vaccine Type, 2021-2031
Figure 18: Global Brucellosis Vaccine Market Value Share Analysis, by Application, 2020 and 2031
Figure 19: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Cattle, 2017-2031
Figure 20: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Sheep & Goat, 2017-2031
Figure 21: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Others, 2017-2031
Figure 22: Global Brucellosis Vaccine Market Attractiveness Analysis, by Application, 2021-2031
Figure 23: Global Brucellosis Vaccine Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 24: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Veterinary Hospitals & Clinics, 2017-2031
Figure 25: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Retail Channels, 2017-2031
Figure 26: Global Brucellosis Vaccine Market Revenue (US$ Mn), by Others, 2017-2031
Figure 27: Global Brucellosis Vaccine Market Attractiveness Analysis, by Distribution Channel, 2021-2031
Figure 28: Global Brucellosis Vaccine Market Value Share Analysis, by Region, 2020 and 2031
Figure 29: Global Brucellosis Vaccine Market Analysis, by Region, 2021-2031
Figure 30: North America Brucellosis Vaccine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 31: North America Brucellosis Vaccine Market Value Share (%), by Country, 2020 and 2031
Figure 32: North America Brucellosis Vaccine Market Attractiveness, by Country, 2021-2031
Figure 33: North America Brucellosis Vaccine Market Value Share Analysis, by Type, 2020 and 2031
Figure 34: North America Brucellosis Vaccine Market Attractiveness, by Type, 2021-2031
Figure 35: North America Brucellosis Vaccine Market Value Share Analysis, by Vaccine Type, 2020 and 2031
Figure 36: North America Brucellosis Vaccine Market Attractiveness, by Vaccine Type, 2021-2031
Figure 37: North America Brucellosis Vaccine Market Value Share Analysis, by Application, 2020 and 2031
Figure 38: North America Brucellosis Vaccine Market Attractiveness, by Application, 2021-2031
Figure 39: North America Brucellosis Vaccine Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 40: North America Brucellosis Vaccine Market Attractiveness, by Distribution Channel, 2021-2031
Figure 41: Europe Brucellosis Vaccine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 42: Europe Brucellosis Vaccine Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 43: Europe Brucellosis Vaccine Market Attractiveness, by Country/Sub-region, 2021-2031
Figure 44: Europe Brucellosis Vaccine Market Value Share Analysis, by Type, 2020 and 2031
Figure 45: Europe Brucellosis Vaccine Market Attractiveness, by Type, 2021-2031
Figure 46: Europe Brucellosis Vaccine Market Value Share Analysis, by Vaccine Type, 2020 and 2031
Figure 47: Europe Brucellosis Vaccine Market Attractiveness, by Vaccine Type, 2021-2031
Figure 48: Europe Brucellosis Vaccine Market Value Share Analysis, by Application, 2020 and 2031
Figure 49: Europe Brucellosis Vaccine Market Attractiveness, by Application, 2021-2031
Figure 50: Europe Brucellosis Vaccine Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 51: Europe Brucellosis Vaccine Market Attractiveness, by Distribution Channel, 2021-2031
Figure 52: Asia Pacific Brucellosis Vaccine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 53: Asia Pacific Brucellosis Vaccine Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 54: Asia Pacific Brucellosis Vaccine Market Attractiveness, by Country/Sub-region, 2021-2031
Figure 55: Asia Pacific Brucellosis Vaccine Market Value Share Analysis, by Type, 2020 and 2031
Figure 56: Asia Pacific Brucellosis Vaccine Market Attractiveness, by Type, 2021-2031
Figure 57: Asia Pacific Brucellosis Vaccine Market Value Share Analysis, by Vaccine Type, 2020 and 2031
Figure 58: Asia Pacific Brucellosis Vaccine Market Attractiveness, by Vaccine Type, 2021-2031
Figure 59: Asia Pacific Brucellosis Vaccine Market Value Share Analysis, by Application, 2020 and 2031
Figure 60: Asia Pacific Brucellosis Vaccine Market Attractiveness, by Application, 2021-2031
Figure 61: Asia Pacific Brucellosis Vaccine Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 62: Asia Pacific Brucellosis Vaccine Market Attractiveness, by Distribution Channel, 2021-2031
Figure 63: Latin America Brucellosis Vaccine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 64: Latin America Brucellosis Vaccine Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 65: Latin America Brucellosis Vaccine Market Attractiveness, by Country/Sub-region, 2021-2031
Figure 66: Latin America Brucellosis Vaccine Market Value Share Analysis, by Type, 2020 and 2031
Figure 67: Latin America Brucellosis Vaccine Market Attractiveness, by Type, 2021-2031
Figure 68: Latin America Brucellosis Vaccine Market Value Share Analysis, by Vaccine Type, 2020 and 2031
Figure 69: Latin America Brucellosis Vaccine Market Attractiveness, by Vaccine Type, 2021-2031
Figure 70: Latin America Brucellosis Vaccine Market Value Share Analysis, by Application, 2020 and 2031
Figure 71: Latin America Brucellosis Vaccine Market Attractiveness, by Application, 2021-2031
Figure 72: Latin America Brucellosis Vaccine Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 73: Latin America Brucellosis Vaccine Market Attractiveness, by Distribution Channel, 2021-2031
Figure 74: Middle East & Africa Brucellosis Vaccine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 75: Middle East & Africa Brucellosis Vaccine Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 76: Middle East & Africa Brucellosis Vaccine Market Attractiveness, by Country/Sub-region, 2021-2031
Figure 77: Middle East & Africa Brucellosis Vaccine Market Value Share Analysis, by Type, 2020 and 2031
Figure 78: Middle East & Africa Brucellosis Vaccine Market Attractiveness, by Type, 2021-2031
Figure 79: Middle East & Africa Brucellosis Vaccine Market Value Share Analysis, by Vaccine Type, 2020 and 2031
Figure 80: Middle East & Africa Brucellosis Vaccine Market Attractiveness, by Vaccine Type, 2021-2031
Figure 81: Middle East & Africa Brucellosis Vaccine Market Value Share Analysis, by Application, 2020 and 2031
Figure 82: Middle East & Africa Brucellosis Vaccine Market Attractiveness, by Application, 2021-2031
Figure 83: Middle East & Africa Brucellosis Vaccine Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 84: Middle East & Africa Brucellosis Vaccine Market Attractiveness, by Distribution Channel, 2021-2031